Phillies sign LHP Jesús Luzardo

Jesús Luzardo earns a C Contract Value Index (CVI) — a fair-market deal that reflects mid-rotation utility rather than premium starter economics. At $11M AAV on a one-year pact, the Phillies are paying for a solid left-handed arm in a stretch-run rotation, but there's a meaningful gap between what this contract costs and what Luzardo has delivered as a consistent performer at the highest level. A one-year structure suggests the team views this as a depth stabilizer rather than a cornerstone investment, which is the right framing; you're not locking in long-term dollars to a pitcher who projects as a backend starter rather than a Cy Young threat. The valuation works if Luzardo stays healthy and slots into a reliable third- or fourth-starter role down the final stretch and into October, but it doesn't account for upside, and at $11M you're paying closer to the market rate for "dependable innings" than for discount value. For a team currently sitting at 37–31 with playoff positioning still in flux, this is the kind of mid-summer stabilization move that makes sense on paper — low risk, moderate commitment — but it's priced as a neutral trade, not a bargain.